Keeping CRISPR/Cas on-Target

Clicks: 384
ID: 116913
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #6 of 12 articles by views in current issues in molecular biology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
CRISPR/Cas, a microbial adaptive immune system, has recently been reshaped as a versatile genome editing approach, endowing genome engineering with high efficiency and robustness. The DNA endonuclease Cas, a component of CRISPR system, is directed to specific target within genomes by guide RNA (gRNA …
Reference Key
m2016currentkeeping Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jamal M;Khan FA;Da L;Habib Z;Dai J;Cao G;;
Journal current issues in molecular biology
Year 2016
DOI
DOI not found
URL
https://www.pubmed.gov/26453843/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE genetic review animals humans pubmed abstract nih national institutes of health national library of medicine reproducibility of results research support non-u.s. gov't genetic engineering faheem ahmed khan crispr-cas systems* muhammad jamal epigenesis pmid:26453843 gang cao

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.